▶ 調査レポート

乳児用調製粉乳成分のグローバル市場(~2027):炭水化物、油脂、プレバイオティクス、タンパク質、ビタミン&ミネラル

• 英文タイトル:Infant Formula Ingredients Market Research Report by Type, Form, Source, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Infant Formula Ingredients Market Research Report by Type, Form, Source, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「乳児用調製粉乳成分のグローバル市場(~2027):炭水化物、油脂、プレバイオティクス、タンパク質、ビタミン&ミネラル」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2304L204
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、258ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:食品
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の当調査レポートでは、世界の乳児用調製粉乳成分市場規模が2021年に189.0億ドル、2022年に205.5億ドルとなり、その後2027年までにCAGR 8.90%で成長して315.4億ドルに達すると予測しています。当書は、乳児用調製粉乳成分の世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別分析(炭水化物、油脂、プレバイオティクス、タンパク質、ビタミン&ミネラル)、形態別分析(液体&半液体、粉末)、原料別分析(無機、有機)、用途別分析(フォローアップミルク、グローイングアップミルク、特殊調製粉乳、標準乳児用調製粉乳)、地域別分析(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)、競争状況、企業情報などの内容を掲載しています。また、当書には、AAK AB、Abbott Laboratories、Arla Foods Ingredients Group P/S、BASF SE、Bio-Rad Laboratories, Inc.、Carbery Food Ingredients Limited、Chr. Hansen Holdings A/S、Danone S.A.、Fonterra Co-Operative Group Limited、Glanbia PLCなどの企業情報が含まれています。

・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の乳児用調製粉乳成分市場規模:種類別
- 炭水化物の市場規模
- 油脂の市場規模
- プレバイオティクスの市場規模
- タンパク質の市場規模
- ビタミン&ミネラルの市場規模
・世界の乳児用調製粉乳成分市場規模:形態別
- 液体&半液体タイプの市場規模
- 粉末タイプの市場規模
・世界の乳児用調製粉乳成分市場規模:原料別
- 無機調製粉乳の市場規模
- 有機調製粉乳の市場規模
・世界の乳児用調製粉乳成分市場規模:用途別
- フォローアップミルクの市場規模
- グローイングアップミルクの市場規模
- 特殊調製粉乳の市場規模
- 標準乳児用調製粉乳の市場規模
・世界の乳児用調製粉乳成分市場規模:地域別
- 南北アメリカの乳児用調製粉乳成分市場規模
アメリカの乳児用調製粉乳成分市場規模
カナダの乳児用調製粉乳成分市場規模
ブラジルの乳児用調製粉乳成分市場規模
...
- アジア太平洋の乳児用調製粉乳成分市場規模
日本の乳児用調製粉乳成分市場規模
中国の乳児用調製粉乳成分市場規模
インドの乳児用調製粉乳成分市場規模
韓国の乳児用調製粉乳成分市場規模
台湾の乳児用調製粉乳成分市場規模
...
- ヨーロッパ/中東/アフリカの乳児用調製粉乳成分市場規模
イギリスの乳児用調製粉乳成分市場規模
ドイツの乳児用調製粉乳成分市場規模
フランスの乳児用調製粉乳成分市場規模
ロシアの乳児用調製粉乳成分市場規模
...
- その他地域の乳児用調製粉乳成分市場規模
・競争状況
・企業情報

The Global Infant Formula Ingredients Market size was estimated at USD 18.90 billion in 2021 and expected to reach USD 20.55 billion in 2022, and is projected to grow at a CAGR 8.90% to reach USD 31.54 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Infant Formula Ingredients to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Carbohydrates, Oils & Fats, Prebiotics, Proteins, and Vitamins & Minerals.

Based on Form, the market was studied across Liquid & Semi-liquid and Powder.

Based on Source, the market was studied across Inorganic and Organic.

Based on Application, the market was studied across Follow-on Formula, Growing-up Milk, Specialty, and Standard Infant Formula.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Infant Formula Ingredients market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Infant Formula Ingredients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Infant Formula Ingredients Market, including AAK AB, Abbott Laboratories, Arla Foods Ingredients Group P/S, BASF SE, Bio-Rad Laboratories, Inc., Carbery Food Ingredients Limited, Chr. Hansen Holdings A/S, Danone S.A., Fonterra Co-Operative Group Limited, Glanbia PLC, Kerry Group PLC, Koninklijke DSM N.V., Lactalis Ingredients, Mead Johnson & Company, LLC by Reckitt Benckiser Group PLC, Nestle S.A., Royal Friesland Campina N.V., Sachsenmilch Leppersdorf GmbH, Saputo Inc., and Vitablend Nederland B.V. by BARENTZ Group.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Infant Formula Ingredients Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Infant Formula Ingredients Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Infant Formula Ingredients Market?
4. What is the competitive strategic window for opportunities in the Global Infant Formula Ingredients Market?
5. What are the technology trends and regulatory frameworks in the Global Infant Formula Ingredients Market?
6. What is the market share of the leading vendors in the Global Infant Formula Ingredients Market?
7. What modes and strategic moves are considered suitable for entering the Global Infant Formula Ingredients Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about infant formula ingredients among working mothers
5.1.1.2. Growing in the infant population
5.1.1.3. Rise in demand for alternate animal milk source
5.1.2. Restraints
5.1.2.1. Digestive difficulties can lead to greater incidences of gas and diarrhea
5.1.2.2. High cost of infant formula products
5.1.3. Opportunities
5.1.3.1. Increasing demand for organic and natural baby food
5.1.3.2. Rise in the collaborative activities in the market
5.1.3.3. Prebiotic and probiotic in baby food
5.1.4. Challenges
5.1.4.1. Risk of contamination in infant formulas
5.2. Cumulative Impact of COVID-19

6. Infant Formula Ingredients Market, by Type
6.1. Introduction
6.2. Carbohydrates
6.3. Oils & Fats
6.4. Prebiotics
6.5. Proteins
6.6. Vitamins & Minerals

7. Infant Formula Ingredients Market, by Form
7.1. Introduction
7.2. Liquid & Semi-liquid
7.3. Powder

8. Infant Formula Ingredients Market, by Source
8.1. Introduction
8.2. Inorganic
8.3. Organic

9. Infant Formula Ingredients Market, by Application
9.1. Introduction
9.2. Follow-on Formula
9.3. Growing-up Milk
9.4. Specialty
9.5. Standard Infant Formula

10. Americas Infant Formula Ingredients Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Infant Formula Ingredients Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Infant Formula Ingredients Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. AAK AB
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Abbott Laboratories
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Arla Foods Ingredients Group P/S
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. BASF SE
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Bio-Rad Laboratories, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Carbery Food Ingredients Limited
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Chr. Hansen Holdings A/S
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Danone S.A.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Fonterra Co-Operative Group Limited
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Glanbia PLC
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Kerry Group PLC
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Koninklijke DSM N.V.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Lactalis Ingredients
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Mead Johnson & Company, LLC by Reckitt Benckiser Group PLC
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Nestle S.A.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Royal Friesland Campina N.V.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Sachsenmilch Leppersdorf GmbH
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Saputo Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Vitablend Nederland B.V. by BARENTZ Group
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing